Dihydrobonducellin

CAS No. 103680-87-1

Dihydrobonducellin( —— )

Catalog No. M31342 CAS No. 103680-87-1

Dihydrobonducellin has immunopharmacological activity, it significantly inhibits the production of IL-2 and IFN-gamma in activated PBMC in a concentration-dependent manner.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 565 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    Dihydrobonducellin
  • Note
    Research use only, not for human use.
  • Brief Description
    Dihydrobonducellin has immunopharmacological activity, it significantly inhibits the production of IL-2 and IFN-gamma in activated PBMC in a concentration-dependent manner.
  • Description
    Dihydrobonducellin has immunopharmacological activity, it significantly inhibits the production of IL-2 and IFN-gamma in activated PBMC in a concentration-dependent manner.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    103680-87-1
  • Formula Weight
    284.3
  • Molecular Formula
    C17H16O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Diatrizoic Acid

    Diatrizoic Acid is an organic, iodinated radiopaque X-ray contrast medium used in diagnostic radiography.

  • 5NAA

    5NAA is a nitroaromatic compound. 5NAA is also the starting material for synthetic dyes and other nitroaromatic compounds. 5NAA is a molecule secreted by Streptomyces scabies.

  • Sibeprenlimab

    Sibeprenlimab (VIS649) is a humanized IgG2 monoclonal antibody that inhibits APRIL and may be investigated for the prevention and treatment of kidney disease (IgAN).